Sonoco ThermoSafe Creating Industrywide PharmaPortal™ Platform Using IBM Blockchain Technology

Sonoco ThermoSafe, a unit of Sonoco (NYSE: SON), the largest global provider of temperature assurance packaging for pharmaceutical distribution, is building PharmaPortal™, a vendor-neutral blockchain platform for use by pharmaceutical manufacturers and carriers. Built on IBM Blockchain Transparent Supply, PharmaPortal intends to address the industry’s needs to trace assets across many different supply chain participants, record a single version of the truth on all events generated on a package’s journey, integrate this data with that of other businesses across an industry-scale network, and provide access controls to help ensure each data owner maintains control over who can access it on the network.

The openly governed blockchain network built on open source technology will initially focus on end-to-end traceability of temperature-controlled drugs, such as vaccines, and provide an audit trail of environmental condition monitoring to help protect the efficacy of these lifesaving, life-extending and life-enhancing medicines. To help drive its development, Sonoco will invite industry leaders to collaborate on the initiative to optimize the safety and efficiency of global temperature controlled pharmaceutical distribution.

“Only through the collaborative efforts of all members of the temperature controlled pharmaceutical distribution process can we achieve the safety and efficiency that the world needs from us in this critical time,” said Howard Coker, president and CEO of Sonoco. “An effort of this magnitude requires a high level of industry engagement to make a meaningful difference in the lives of people around the world. IBM has had success working across a number of sectors where implementing blockchain networks transformed the efficiency and effectiveness of the supply chain, and we see the same opportunities in the pharmaceutical space.”

Despite improvements, the $230B cold chain pharmaceutical distribution market still suffers from inefficiencies, which cause value losses estimated at nearly $35B. These encompass lost product inventory, root cause investigation costs, clinical trial opportunity losses, product replacement costs and redundant logistics. Multiple handoffs across contracted and sub-contracted handling agents across continents create a crucial need for trusted, end-to-end visibility of pharmaceutical shipments, conditions and documents.

“IBM offers deep expertise in blockchain to the pharmaceutical industry to help establish this transformational network led by Sonoco ThermoSafe,” said Raj Rao, general manager, Blockchain Platforms. “With Blockchain’s inherent ability to track drug provenance and create an immutable record of the lifecycle of a drug and how it was handled, this open industry initiative addresses the challenges the pharmaceutical industry faces, both in sourcing and distributing drugs.”

This neutral ecosystem will be especially helpful in fostering trust in the pharmaceutical air cargo market by enabling all parties in the supply chain to give and get relevant data in a highly secured, permissioned way.”

As the convener of the network, Sonoco ThermoSafe intends to create a permissioned platform for the industry that will ultimately create more visibility and transparency across the pharmaceutical supply chain. With network growth in the coming months, a PharmaPortal Advisory Council will be appointed and comprised of a range of pharmaceutical industry representatives willing to participate in its development and adoption and help openly govern the network so that the solution benefits all.
https://investor.sonoco.com/news-releases/news-release-details/sonoco-thermosafe-creating-industrywide-pharmaportaltm-platform

Related Posts

Spanish fashion retailer Alvaro Moreno to save 90 tonnes of plastic per year by switching to more sustainable packaging from Mondi

Mondi has helped Spanish retail chain Alvaro Moreno to save almost 90 tonnes of plastic per year by switching from plastic to paper shopping, online delivery and gift bags. In the past, Alvaro Moreno used more than 3.7 million plastic bags and containers per year. By switching to paper packaging for its bags and thus reducing its plastic consumption, the company is demonstrating its commitment to sustainability. All three bags are recyclable and made from Mondi’s Advantage and EcoVantage product ranges using renewable and responsibly sourced materials. EcoVantage is Mondi’s newest paper range created with fresh pulp and recycled fibres, providing a high-quality printing surface to feature the brand’s distinct white logo and promote the sustainability benefits for its customers.

UPM Raflatac achieves APR Critical Guidance Recognition for HDPE container label materials

UPM Raflatac is pleased to announce that the Association of Plastic Recyclers (APR) has recognized its PE and PP pressure sensitive label materials with general purpose acrylic adhesive for high-density polyethylene (HDPE) containers as meeting or exceeding the most strict APR HDPE Critical Guidance criteria for recyclability. Achieving this Critical Guidance Recognition is an important step in UPM Raflatac’s ongoing quest to label a smarter future beyond fossils. These white and clear PP and PE label materials combined with multipurpose acrylic adhesives are part of UPM Raflatac’s SmartCircle™ portfolio of labeling materials that enable recyclability of packaging and promote the circular economy. The Critical Guidance Recognition means the label materials are proven to be compatible with standard HDPE container recycling practices. They are suitable for a variety of end-uses, including food and home and personal care.

Intertape Polymer Group (IPG®) Completes Transaction to Acquire Cantech®

Intertape Polymer Group Inc. announced the completion on July 1 of the previouslyannounced transaction to acquire substantially all of the assets of Canadian Technical Tape Ltd. (d/b/a “Cantech”), a North American supplier of industrial and specialty tapes based in Montreal. The expected aggregate purchase price is approximately $67 million (as updated from the previously-communicated purchase price of $63 million due to certain purchase price adjustments), subject to further post-closing adjustments. All amounts in this press release are denominated in US dollars. Click Read More below for additional detail.
Back To Top
×Close search
Search